Induced Pluripotent Stem Cells Production market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells Production market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Segment by Application
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
By Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
